Fisher & Paykel Healthcare Corporation Limited today announced record net profit after tax of NZ$62.0 million for the half year ended 30 Sept 2015, an increase of 27% over the first half last year.
Read more
Fisher & Paykel Healthcare Corporation Limited today announced its results for the half year ended 30 September 2016. Net profit after tax was up 26% for the half at a record NZ$78.2 million.
Fisher & Paykel Healthcare Corporation Limited today announced its results for the half year ended 30 September 2018. Net profit after tax was NZ$97.4 million, up 20%.
Fisher & Paykel Healthcare today announced a record result for the 2019 financial year, with net profit after tax up 10% to NZ$209.2 million.
Fisher & Paykel Healthcare Corporation Limited announced today its results for the full year ended 31 March 2020. Operating revenue was $1.26 billion, up 18% over last year.
Fisher & Paykel Healthcare Corporation Limited today announced its results for the first half of the 2021 financial year, which ended 30 September 2020.
Fisher & Paykel Healthcare Corporation Limited today announced its results for the full year ended 31 March 2021.
Fisher & Paykel Healthcare Corporation Limited today announced its results for the first half of the 2022 financial year.
Evidence and guidance for delivering Optiflow NHF, proven respiratory support for your patients.
The heating and humidifying of respiratory gases is crucial for intubated patients. Learn about humidification devices, including active and passive.
Featuring under nose NIV masks and full face NIV masks, with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Noninvasive respiratory support that provides a continuous distending pressure
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Delivering warm, humidified carbon dioxide in laparoscopic and open surgery
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
Nasal High Flow and Humidification for patients at home and in long term care
Home respiratory therapies that deliver humidification via a mask or tracheotomy tube to support and complement the airway’s natural-defense mechanisms
Our newest Airvo features an integrated battery, high-pressure oxygen input and a broader flow range.
Optiflow nasal high flow therapy explained, what is it and how does it work?
F&P Solo™ is the world’s first AutoFit™ mask. It simplifies setup like no other, using AutoLock™ technology - stretch to fit, touch to adjust.
Airvo, F&P 950 and F&P 850 – this trio of humidification and respiratory support devices facilitate multiple respiratory therapies across the hospital
Join our global team. View and apply for jobs with us.
Get in touch with our team, find a distributor or send an enquire.
We value your privacy. Our websites and applications use cookies to function properly and securely.